BioCentury | Sep 7, 2016
Company News

FDA recommends against ovarian cancer screening tests

...sensitive enough to "reliably" screen for ovarian cancer "without a high number of inaccurate results." Abcodia Ltd....
...the U.K. Collaborative Trial for Ovarian Cancer Screening. FDA said available data do not support Abcodia's...
BioCentury | Aug 22, 2016
Financial News

Cambridge Innovation Capital plc financial update

...the Cambridge Cluster. It also plans to provide additional investment to its portfolio, which includes Abcodia Ltd....
BioCentury | Aug 19, 2016
Financial News

Cambridge Innovation raises L75M

...L33 million ($42.7 million) in 13 companies to date. Its healthcare investments include biobanking company Abcodia Ltd....
BioCentury | May 25, 2015
Financial News

Abcodia completes venture financing

Abcodia Ltd. , London, U.K. Business: Diagnostic, Pharmacogenetics Date completed: 2015-05-18 Type: Venture financing Raised: L5.3 million ($8.2 million) Investors: Cambridge Innovation Capital plc; Scottish Equity Partners; Albion Ventures; UCL Business plc WIR Staff...
BioCentury | Nov 17, 2014
Tools & Techniques

Abcodia's (bio)bankroll

...be collected through an NHS center, as well as through hospital statistics and death certificates. Abcodia...
...IP generated by UCL researchers, who continue to use the samples for their own work. Abcodia...
...and Institutions Mentioned Abcodia Ltd. , London, U.K. University College London, London, U.K. References Cukier-Meisner, E. "Abcodia...
BioCentury | Sep 30, 2013
Company News

Abcodia, Massachusetts General Hospital deal

...The hospital granted Abcodia exclusive, worldwide rights to commercialize the risk of ovarian cancer algorithm (ROCA...
...of Ovarian Cancer Study at the University of Texas MD Anderson Cancer Center (Houston, Texas). Abcodia...
...a deal with Queen Mary University London (London, U.K.). Abcodia declined to provide financial details. Abcodia Ltd....
BioCentury | Aug 5, 2013
Company News

Abcodia, Cellmid deal

...indications, but the partners will initially focus on early detection and screening of colorectal cancer. Abcodia...
...Ovarian Cancer screening, and Cellmid will carry out testing. The partners declined to disclose details. Abcodia Ltd....
BioCentury | Jul 11, 2013
Translation in Brief

Translational tidbits

...in which academics apply to partner with Shionogi to discover and develop new drug therapies Abcodia Ltd....
BioCentury | Jun 17, 2013
Company News

Abcodia, AIT Austrian Institute of Technology deal

...studies to validate panels of biomarkers for the early detection of lung and colorectal cancers. Abcodia...
...provide its samples free of charge, and AIT will test the samples free of charge. Abcodia...
...a data package that will allow the licensing of the IP to a commercial partner. Abcodia...
BioCentury | Jun 10, 2013
Company News

Abcodia, Cancer Research U.K. deal

...Cancer Research U.K. and its Cancer Research Technology Ltd. (CRT) commercial arm partnered with Abcodia to...
...tests to detect a range of cancers when they are still early stage and asymptomatic. Abcodia...
...will seek additional academic and commercial partners to discover, validate and further develop any biomarkers. Abcodia...
Items per page:
1 - 10 of 17
BioCentury | Sep 7, 2016
Company News

FDA recommends against ovarian cancer screening tests

...sensitive enough to "reliably" screen for ovarian cancer "without a high number of inaccurate results." Abcodia Ltd....
...the U.K. Collaborative Trial for Ovarian Cancer Screening. FDA said available data do not support Abcodia's...
BioCentury | Aug 22, 2016
Financial News

Cambridge Innovation Capital plc financial update

...the Cambridge Cluster. It also plans to provide additional investment to its portfolio, which includes Abcodia Ltd....
BioCentury | Aug 19, 2016
Financial News

Cambridge Innovation raises L75M

...L33 million ($42.7 million) in 13 companies to date. Its healthcare investments include biobanking company Abcodia Ltd....
BioCentury | May 25, 2015
Financial News

Abcodia completes venture financing

Abcodia Ltd. , London, U.K. Business: Diagnostic, Pharmacogenetics Date completed: 2015-05-18 Type: Venture financing Raised: L5.3 million ($8.2 million) Investors: Cambridge Innovation Capital plc; Scottish Equity Partners; Albion Ventures; UCL Business plc WIR Staff...
BioCentury | Nov 17, 2014
Tools & Techniques

Abcodia's (bio)bankroll

...be collected through an NHS center, as well as through hospital statistics and death certificates. Abcodia...
...IP generated by UCL researchers, who continue to use the samples for their own work. Abcodia...
...and Institutions Mentioned Abcodia Ltd. , London, U.K. University College London, London, U.K. References Cukier-Meisner, E. "Abcodia...
BioCentury | Sep 30, 2013
Company News

Abcodia, Massachusetts General Hospital deal

...The hospital granted Abcodia exclusive, worldwide rights to commercialize the risk of ovarian cancer algorithm (ROCA...
...of Ovarian Cancer Study at the University of Texas MD Anderson Cancer Center (Houston, Texas). Abcodia...
...a deal with Queen Mary University London (London, U.K.). Abcodia declined to provide financial details. Abcodia Ltd....
BioCentury | Aug 5, 2013
Company News

Abcodia, Cellmid deal

...indications, but the partners will initially focus on early detection and screening of colorectal cancer. Abcodia...
...Ovarian Cancer screening, and Cellmid will carry out testing. The partners declined to disclose details. Abcodia Ltd....
BioCentury | Jul 11, 2013
Translation in Brief

Translational tidbits

...in which academics apply to partner with Shionogi to discover and develop new drug therapies Abcodia Ltd....
BioCentury | Jun 17, 2013
Company News

Abcodia, AIT Austrian Institute of Technology deal

...studies to validate panels of biomarkers for the early detection of lung and colorectal cancers. Abcodia...
...provide its samples free of charge, and AIT will test the samples free of charge. Abcodia...
...a data package that will allow the licensing of the IP to a commercial partner. Abcodia...
BioCentury | Jun 10, 2013
Company News

Abcodia, Cancer Research U.K. deal

...Cancer Research U.K. and its Cancer Research Technology Ltd. (CRT) commercial arm partnered with Abcodia to...
...tests to detect a range of cancers when they are still early stage and asymptomatic. Abcodia...
...will seek additional academic and commercial partners to discover, validate and further develop any biomarkers. Abcodia...
Items per page:
1 - 10 of 17